These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27155719)

  • 1. [IgG1 antibody allows the first targeted therapy].
    Einecke D
    MMW Fortschr Med; 2016 May; 158(9):70. PubMed ID: 27155719
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Ciuleanu T; Socinski MA; Obasaju C; Luft AV; Szczesna A; Szafrański W; Ramlau R; Bálint B; Molinier O; Depenbrock H; Nanda S; Paz-Ares L; Thatcher N
    Clin Lung Cancer; 2018 Mar; 19(2):130-138.e2. PubMed ID: 29158123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necitumumab: First Global Approval.
    Garnock-Jones KP
    Drugs; 2016 Feb; 76(2):283-9. PubMed ID: 26729188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necitumumab for the treatment of advanced non-small-cell lung cancer.
    Díaz-Serrano A; Sánchez-Torre A; Paz-Ares L
    Future Oncol; 2019 Mar; 15(7):705-716. PubMed ID: 30501503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating novel agents with gemcitabine-based treatment of NSCLC.
    Treat J
    Lung Cancer; 2005 Oct; 50 Suppl 1():S8-9. PubMed ID: 16291433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Budget Impact of Including Necitumumab on the Formulary for First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer: U.S. Commercial Payer and Medicare Perspectives.
    Bly CA; Molife C; Brown J; Tawney MK; Carter GC; Cinfio FN; Klein RW
    J Manag Care Spec Pharm; 2018 Jun; 24(6):534-543. PubMed ID: 29799326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necitumumab in the treatment of non-small-cell lung cancer: clinical controversies.
    di Noia V; D'Argento E; Pilotto S; Grizzi G; Caccese M; Iacovelli R; Tortora G; Bria E
    Expert Opin Biol Ther; 2018 Sep; 18(9):937-945. PubMed ID: 30075697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine maintenance therapy after gemcitabine and platinum drug chemotherapy for naive stage IIIB/IV squamous cell lung cancer: a phase II study.
    Hamai K; Fujitaka K; Kitaguchi S; Tamamoto S; Takao S; Nishida A; Furutama J; Horimasu Y; Masuda T; Miyamoto S; Awaya Y; Kondo T; Shoda H; Ishikawa N; Yamasaki M; Hattori N
    Anticancer Drugs; 2021 Aug; 32(7):767-772. PubMed ID: 33967202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial.
    Reck M; Socinski MA; Luft A; Szczęsna A; Dediu M; Ramlau R; Losonczy G; Molinier O; Schumann C; Gralla RJ; Bonomi P; Brown J; Soldatenkova V; Chouaki N; Obasaju C; Peterson P; Thatcher N
    J Thorac Oncol; 2016 Jun; 11(6):808-18. PubMed ID: 26980471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL).
    Leighl NB; Zatloukal P; Mezger J; Ramlau R; Moore N; Reck M; Manegold C
    J Thorac Oncol; 2010 Dec; 5(12):1970-6. PubMed ID: 20978447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan.
    Watanabe S; Yoshioka H; Sakai H; Hotta K; Takenoyama M; Yamada K; Sugawara S; Takiguchi Y; Hosomi Y; Tomii K; Niho S; Yamamoto N; Nishio M; Ohe Y; Kato T; Takahashi T; Kamada A; Suzukawa K; Omori Y; Enatsu S; Nakagawa K; Tamura T
    Lung Cancer; 2019 Mar; 129():55-62. PubMed ID: 30797492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer.
    Tai CJ; Hsu CH; Wang FJ; Chau WK; Chung CL; Hsieh CC
    Onkologie; 2009 Nov; 32(11):685-6. PubMed ID: 19887875
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung squamous cell carcinoma with severe hypomagnesemia due to cisplatin plus gemcitabine in combination with necitumumab therapy: A case report.
    Nakao A; Inoue H; Osaki Y; Hirano R; Harada T; Aoyama T; Igata F; Fujita M
    Thorac Cancer; 2021 Jul; 12(13):2039-2042. PubMed ID: 34061460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer.
    DeLozier AM; Brown J; Natanegara F; Zhao L; Cui ZL; Able SL; Bowman L; Treat J; Hess LM
    Syst Rev; 2014 Sep; 3():102. PubMed ID: 25227571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of gemcitabine in treatment of metastatic breast cancer].
    Latipova DKh; Semiglazova TIu; Filatova LV; Gershanovich ML
    Vopr Onkol; 2011; 57(2):139-46. PubMed ID: 21809657
    [No Abstract]   [Full Text] [Related]  

  • 16. Cetuximab and cisplatin for chemotherapy-refractory squamous cell cancer of the head and neck.
    Burtness B
    J Clin Oncol; 2005 Aug; 23(24):5440-2. PubMed ID: 16009959
    [No Abstract]   [Full Text] [Related]  

  • 17. Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.
    Bischoff HG; Heigener DF; Walzer S; Nuijten M
    Lung Cancer; 2010 Aug; 69 Suppl 1():S18-23. PubMed ID: 20727458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approval summary: pemetrexed in the initial treatment of advanced/metastatic non-small cell lung cancer.
    Cohen MH; Justice R; Pazdur R
    Oncologist; 2009 Sep; 14(9):930-5. PubMed ID: 19737998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal toxicity with a gemcitabine-cisplatin combination in lung cancer].
    Margery J; Vaylet F; Guigay J; Grassin F; Morel V; L'Her P
    Presse Med; 2002 May; 31(17):794. PubMed ID: 12148362
    [No Abstract]   [Full Text] [Related]  

  • 20. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
    Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
    Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.